Anal cancer
Disease8 papers1 finding
- Human trial2
- Humans3
- In silico1
Associations
1Treatment of anal high-grade squamous intraepithelial lesions
downin humans1−57%
1 study
Treatment of anal high-grade squamous intraepithelial lesions
downin humans1−57%
Treatment of anal high-grade squamous intraepithelial lesions lower the risk of anal cancer in humans (57%).
Reviewanal high-grade squamous intraepithelial lesions in ANCHOR trial
Elimination of HPV-associated cancers: universal HPV vaccination and the role of anal screening - a meeting report · BMC proceedings · 22 Sep 2026
Treatment of anal high-grade squamous intraepithelial lesions →
Trial sponsors
2 trialsPhase 3366 people
Radiation Therapy Oncology Group
1 trialPhase 3682 people
University College London (UCL) Cancer Institute
1 trialPhase 3600 people
Sixth Affiliated Hospital, Sun Yat-sen University
1 trialPhase 3102 people
European Organisation for Research and Treatment of Cancer - EORTC
1 trialPhase 2/388 people
GERCOR - Multidisciplinary Oncology Cooperative Group
1 trialPhase 297 people
ECOG-ACRIN Cancer Research Group
1 trialPhase 263 people
1 trialPhase 220 people
Funding
National Cancer InstituteUS$3.6mNational Institute of Biomedical Imaging and BioengineeringUS$353.7k4 grants since 2023
Screening Strategies Among High-Risk Populations for Anal Cancer
National Cancer InstituteEmory UniversityUS$3m2023–2029
Optimization of anal cancer screening for people with HIV using genomic methods
National Cancer InstituteIcahn School of Medicine at Mount SinaiUS$182.2k2024–2029
Leveraging Social Media Influencers to Improve Anal Cancer Prevention
National Cancer InstituteTemple Univ of the CommonwealthUS$407.5k2026–2028
Probe-Based Light Sheet Microscopy (pLSM) for Screening of Anal Cancer
National Institute of Biomedical Imaging and BioengineeringUniversity of ArizonaUS$353.7k2025–2028